They just raised $28m
Hardly a shambles.
Bubs is/was at 30% capacity of its relatively new Deloraine facility, so allowing for huge growth into 2021Yr via new Vita bubs product and expected China growth from new SAMR accreditation
Ann: MOU to Manufacture SAMR Infant Formula in China, page-161
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $116.1M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $16.51K | 126.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 1352221 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 412557 | 7 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| BUB (ASX) Chart |